Search by Drug Name or NDC

    NDC 00310-6225-60 XIGDUO 2.5; 1000 mg/1; mg/1 Details

    XIGDUO 2.5; 1000 mg/1; mg/1

    XIGDUO is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AstraZeneca Pharmaceuticals LP. The primary component is DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE.

    Product Information

    NDC 00310-6225
    Product ID 0310-6225_7d19a7d8-7419-4bf1-8462-52894fe73902
    Associated GPIs 27996002307507
    GCN Sequence Number 078062
    GCN Sequence Number Description dapaglifloz propaned/metformin TAB BP 24H 2.5-1000MG ORAL
    HIC3 C4E
    HIC3 Description ANTIHYPERGLYCEMIC-SGLT2 INHIBITOR-BIGUANIDE COMBS.
    GCN 44304
    HICL Sequence Number 041188
    HICL Sequence Number Description DAPAGLIFLOZIN PROPANEDIOL/METFORMIN HCL
    Brand/Generic Brand
    Proprietary Name XIGDUO
    Proprietary Name Suffix XR
    Non-Proprietary Name dapagliflozin and metformin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 2.5; 1000
    Active Ingredient Units mg/1; mg/1
    Substance Name DAPAGLIFLOZIN PROPANEDIOL; METFORMIN HYDROCHLORIDE
    Labeler Name AstraZeneca Pharmaceuticals LP
    Pharmaceutical Class Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA205649
    Listing Certified Through 2024-12-31

    Package

    NDC 00310-6225-60 (00310622560)

    NDC Package Code 0310-6225-60
    Billing NDC 00310622560
    Package 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0310-6225-60)
    Marketing Start Date 2018-01-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 9.33604
    Pricing Unit EA
    Effective Date 2024-01-01
    NDC Description XIGDUO XR 2.5 MG-1,000 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis